knowledge -WSS

knowledge

author：fashion 2025-08-31 20:52:15 - browse：4827

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

WSS

European regulators recommend Amylyx's ALS drug be rejected

How doctors and nurses shape Google's AI

Nick Jonas talks about managing diabetes along with his career

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

A fraught question for the kids of Alzheimer’s: Is it coming for us?

A fraught question for the kids of Alzheimer’s: Is it coming for us?

knowledge

knowledge

focus

Hepatitis C has a cure — but many Americans still lack access to it

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Supreme Court strikes down use of affirmative action

The White House hikes tariffs on plastic syringes made in China

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A revolution in caring for preterm infants

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What a koala virus tells us about the human genome

Hepatitis C has a cure — but many Americans still lack access to it

What the Wegovy shortage looks like for doctors — and for patients

hotspot

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Cancer cells are shown to suck energy source from immune cells

How doctors and nurses shape Google's AI

How should state employee insurance handle Wegovy?

WuXi Biologics execs register to lobby as Congress comes for the company

Supreme Court to hear if Covid misinformation is protected speech

knowledge

hotspot

Wikipedia

Wikipedia